Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
| ▸ | CFD | P00746 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.33 |
| ▸ | TUBB | P07437 | 1/20 | 0.33 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.33 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.33 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.33 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.33 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.33 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.33 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.33 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.33 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.33 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.33 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30423749 | 1.00 | CA2 (0.41) | CA2GAAAKT1CFDCYP2A6 | |
| SCHEMBL11854282 | 0.91 | AKT1 (0.40) | AKT1CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL27516451 | 0.80 | L3MBTL1 (0.40) | CA2GAAALDH1A1SLC6A4HSD17B10 | |
| SCHEMBL8993094 | 0.78 | GABRA1 (0.41) | CA2ALDH1A1 | |
| SCHEMBL727075 | 0.78 | ESR1 (0.44) | CA2GAACFDALDH1A1TUBB4A | |
| SCHEMBL30259656 | 0.78 | ESR1 (0.44) | CA2GAACFDALDH1A1TUBB4A | |
| SCHEMBL20286678 | 0.77 | CA2 (0.63) | CA2GAAALDH1A1TUBB4ATUBB | |
| SCHEMBL8518746 | 0.76 | CYP2A6 (0.39) | AKT1CYP2A6ALDH1A1HSD17B10KMT2A | |
| SCHEMBL23597026 | 0.76 | DHFR (0.36) | DHFR | |
| SCHEMBL829807 | 0.74 | CYP3A4 (0.44) | CA2GAAALDH1A1SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8575239-B2 | Curing composition and cured product prepared by using the same | LG CHEM, LTD. (KR) | 2013-11-05 | — | — | US | claimed |
| EP-2231781-B1 | CURING COMPOSITION AND CURED PRODUCT PREPARED BY USING THE SAME | LG CHEMICAL LTD (KR) | 2012-09-26 | — | — | EP | claimed |
| JP-2011525198-A | — | — | 2011-09-15 | — | — | JP | claimed |
| US-20100286302-A1 | CURING COMPOSITION AND CURED PRODUCT PREPARED BY USING THE SAME | SHANJIN OPTOELECTRONICS (SUZHOU) CO., LTD. (CN) | 2010-11-11 | — | — | US | claimed |
| EP-2231781-A2 | CURING COMPOSITION AND CURED PRODUCT PREPARED BY USING THE SAME | LG Chem, Ltd. (KR) | 2010-09-29 | — | — | EP | claimed |
| WO-2009084861-A2 | CURING COMPOSITION AND CURED PRODUCT PREPARED BY USING THE SAME | LG CHEM, LTD. (KR) | 2009-07-09 | — | — | WO | claimed |
| US-12565608-B2 | Thermally conductive resin composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-03 | — | — | US | disclosed |
| US-20250382414-A1 | RECYCLABLE AND MALLEABLE THERMOSETS ENABLED BY ACTIVATING DORMANT DYNAMIC LINKAGES | UNIV COLORADO REGENTS (US) | 2025-12-18 | — | — | US | disclosed |
| CN-119998359-A | Recoverable and extensible thermoset achieved by activation of dormant dynamic bonds | 科罗拉多大学董事会, 法人团体 | 2025-05-13 | — | — | CN | disclosed |
| US-20250001725-A1 | GLASS CLOTH COMPOSITE MATERIAL | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-01-02 | — | — | US | disclosed |
| US-20240351981-A1 | NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2024-10-24 | — | — | US | disclosed |
| CN-116157915-B | Thermosetting resin composition and semiconductor device | 信越化学工业株式会社 | 2024-09-24 | — | — | CN | disclosed |
| EP-4380922-A1 | NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS | Evonik Operations GmbH (DE) | 2024-06-12 | — | — | EP | disclosed |
| EP-1208159-A1 | CYANATE ESTER BASED THERMOSET COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2002-05-29 | — | — | EP | disclosed |
| US-20010016616-A1 | Cyanate ester based thermoset compositions | CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT (FIRST LIEN) | 2001-08-23 | — | — | US | disclosed |
| US-6245841-B1 | BLEND CONTAINING FLAME RETARDER AND CURING AGENT | GENERAL ELECTRIC COMPANY | 2001-06-12 | — | — | US | disclosed |
| US-6194495-B1 | CURBLE COMPOSITION WITH ARYLOXYTRIAZINE | GENERAL ELECTRIC COMPANY | 2001-02-27 | — | — | US | disclosed |
| WO-2001009247-A1 | CYANATE ESTER BASED THERMOSET COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2001-02-08 | — | — | WO | disclosed |
| US-6162876-A | Cyanate ester based thermoset compositions | GENERAL ELECTRIC COMPANY (US) | 2000-12-19 | — | — | US | disclosed |
| EP-0945477-A1 | Cyanate ester based thermoset compositions | GENERAL ELECTRIC COMPANY (US) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565608-B2 | Thermally conductive resin composition | ITGAM, RAE1, FCGR1A | CA2 1047/4885GAA 4416/4885AKT1 1869/4885 |
| US-20250382414-A1 | RECYCLABLE AND MALLEABLE THERMOSETS ENABLED BY ACTIVATING DORMANT DYNAMIC LINKAGES | CDK4, TRIB2, KDM4B | CA2 3822/4885GAA 4366/4885AKT1 3622/4885 |
| US-20240351981-A1 | NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS | PBRM1, SMCHD1, SMARCE1 | CA2 1507/4885GAA 2325/4885AKT1 3359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.